PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.17%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
18.90%
Positive gross profit growth while AVGO is negative. John Neff would see a clear operational edge over the competitor.
59.50%
EBIT growth above 1.5x AVGO's 7.28%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
59.50%
Operating income growth above 1.5x AVGO's 7.28%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
40.10%
Net income growth at 75-90% of AVGO's 46.23%. Bill Ackman would press for improvements to catch or surpass competitor performance.
43.75%
EPS growth at 75-90% of AVGO's 53.85%. Bill Ackman would push for improved profitability or share repurchases to catch up.
43.75%
Diluted EPS growth at 50-75% of AVGO's 62.16%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.33%
Share reduction more than 1.5x AVGO's 0.75%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
0.70%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
30.00%
OCF growth at 75-90% of AVGO's 38.37%. Bill Ackman would demand better working capital management or cost discipline.
39.02%
FCF growth similar to AVGO's 38.44%. Walter Schloss would attribute it to parallel capital spending and operational models.
198.11%
10Y revenue/share CAGR under 50% of AVGO's 561.74%. Michael Burry would suspect a lasting competitive disadvantage.
114.36%
5Y revenue/share CAGR at 75-90% of AVGO's 128.89%. Bill Ackman would encourage strategies to match competitor’s pace.
58.36%
3Y revenue/share CAGR above 1.5x AVGO's 37.72%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
521.80%
10Y OCF/share CAGR under 50% of AVGO's 1558.23%. Michael Burry would worry about a persistent underperformance in cash creation.
791.09%
5Y OCF/share CAGR above 1.5x AVGO's 211.80%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
346.05%
3Y OCF/share CAGR above 1.5x AVGO's 103.98%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
570.53%
Net income/share CAGR above 1.5x AVGO's 271.28% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
295.37%
5Y net income/share CAGR above 1.5x AVGO's 5.30%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
91.31%
3Y net income/share CAGR above 1.5x AVGO's 28.59%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
312.81%
Below 50% of AVGO's 1085.55%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
120.09%
Below 50% of AVGO's 279.76%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
102.30%
3Y equity/share CAGR above 1.5x AVGO's 24.01%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
89.38%
Below 50% of AVGO's 797.50%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
38.60%
Below 50% of AVGO's 217.59%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
25.68%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-15.57%
Inventory is declining while AVGO stands at 0.95%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.38%
Asset growth above 1.5x AVGO's 0.67%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.16%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
0.08%
Debt shrinking faster vs. AVGO's 2.56%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
4.45%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
0.76%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.